BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

302 related articles for article (PubMed ID: 22948219)

  • 21. Prostatic elasticity: a new non-invasive parameter to assess bladder outlet obstruction caused by benign prostatic hyperplasia (a canine experiment).
    Fu S; Zhang M; Wang Y; Li Q; Tang J
    Urology; 2013 Nov; 82(5):1114-9. PubMed ID: 24242892
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Pre-treatment serum testosterone level can be a useful factor to predict the improvement in bladder outlet obstruction by tadalafil for male patients with lower urinary tract symptoms induced by benign prostatic obstruction.
    Matsukawa Y; Kanada Y; Takai S; Inoue S; Majima T; Funahashi Y; Kato M; Yamamoto T; Gotoh M
    Aging Male; 2020 Dec; 23(5):641-647. PubMed ID: 30651033
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Interrelationships of bladder compliance with age, detrusor instability, and obstruction in elderly men with lower urinary tract symptoms.
    Madersbacher S; Pycha A; Klingler CH; Mian C; Djavan B; Stulnig T; Marberger M
    Neurourol Urodyn; 1999; 18(1):3-15. PubMed ID: 10090122
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Videourodynamic findings of lower urinary tract dysfunctions in men with persistent storage lower urinary tract symptoms after medical treatment.
    Jiang YH; Wang CC; Kuo HC
    PLoS One; 2018; 13(2):e0190704. PubMed ID: 29462145
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Noninvasive methods to evaluate bladder obstruction in men.
    Elterman DS; Chughtai B; Lee R; Te AE; Kaplan SA
    Int Braz J Urol; 2013; 39(1):4-9. PubMed ID: 23489514
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Radiotelemetered urodynamics of obstructed ovine fetal bladders: correlations with ex vivo cystometry and renal histopathology.
    Farrugia MK; Woolf AS; Fry CH; Peebles DM; Cuckow PM; Godley ML
    BJU Int; 2007 Jun; 99(6):1517-22. PubMed ID: 17355367
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Prostatic stromal inflammation is associated with bladder outlet obstruction in patients with benign prostatic hyperplasia.
    Inamura S; Ito H; Shinagawa T; Tsutsumiuchi M; Taga M; Kobayashi M; Yokoyama O
    Prostate; 2018 Jul; 78(10):743-752. PubMed ID: 29608020
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Androgens and bladder outlet obstruction: a correlation with pressure-flow variables in a preliminary study.
    Koritsiadis G; Stravodimos K; Mitropoulos D; Doumanis G; Fokitis I; Koritsiadis S; Constantinides C
    BJU Int; 2008 Jun; 101(12):1542-6. PubMed ID: 18294304
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Morphometric analysis of symptomatic benign prostatic hyperplasia with and without bladder outlet obstruction.
    Ichiyanagi O; Sasagawa I; Ishigooka M; Suzuki Y; Nakada T
    Urol Res; 2000 Jan; 28(1):29-32. PubMed ID: 10732692
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Applying bladder outlet obstruction number to predict bladder outlet obstruction of benign prostatic hyperplasia].
    Zhang P; Wu ZJ; Yang Y; Zhang XD
    Zhonghua Wai Ke Za Zhi; 2008 Aug; 46(15):1156-9. PubMed ID: 19094679
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Comprehensive patient evaluation for benign prostatic hyperplasia.
    Jepsen JV; Bruskewitz RC
    Urology; 1998 Apr; 51(4A Suppl):13-8. PubMed ID: 9586591
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Positioning invasive versus noninvasive urodynamics in the assessment of bladder outlet obstruction.
    Arnolds M; Oelke M
    Curr Opin Urol; 2009 Jan; 19(1):55-62. PubMed ID: 19057217
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Endocrine disruptor bisphenol A is implicated in urinary voiding dysfunction in male mice.
    Nicholson TM; Nguyen JL; Leverson GE; Taylor JA; Vom Saal FS; Wood RW; Ricke WA
    Am J Physiol Renal Physiol; 2018 Nov; 315(5):F1208-F1216. PubMed ID: 30019933
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Effects of isocorynoxeine, from Uncaria, on lower urinary tract dysfunction caused by benign prostatic hyperplasia via antagonism of α
    Li T; Xu K; He J; Jahan N; Song J; Wang S
    Toxicol Appl Pharmacol; 2019 Aug; 376():95-106. PubMed ID: 31145917
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Bladder-outlet obstruction--assessment of symptoms.
    Reynard JM; Abrams P
    World J Urol; 1995; 13(1):3-8. PubMed ID: 7539678
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The detrusor muscle: an innocent victim of bladder outlet obstruction.
    Mirone V; Imbimbo C; Longo N; Fusco F
    Eur Urol; 2007 Jan; 51(1):57-66. PubMed ID: 16979287
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Solifenacin plus tamsulosin combination treatment in men with lower urinary tract symptoms and bladder outlet obstruction: a randomized controlled trial.
    Kaplan SA; He W; Koltun WD; Cummings J; Schneider T; Fakhoury A
    Eur Urol; 2013 Jan; 63(1):158-65. PubMed ID: 22831853
    [TBL] [Abstract][Full Text] [Related]  

  • 38. BPH with coexisting overactive bladder dysfunction--an everyday urological dilemma.
    Knutson T; Edlund C; Fall M; Dahlstrand C
    Neurourol Urodyn; 2001; 20(3):237-47. PubMed ID: 11385690
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Correlation of the factors on benign prostatic hyperplasia combined with obstruction].
    Chen Q; Wang YX
    Zhonghua Nan Ke Xue; 2002; 8(4):299-301. PubMed ID: 12491701
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The ICS-'BPH' Study: uroflowmetry, lower urinary tract symptoms and bladder outlet obstruction.
    Reynard JM; Yang Q; Donovan JL; Peters TJ; Schafer W; de la Rosette JJ; Dabhoiwala NF; Osawa D; Lim AT; Abrams P
    Br J Urol; 1998 Nov; 82(5):619-23. PubMed ID: 9839573
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 16.